Health and Social Protection Minister Amine Tahraoui has called on healthcare professionals to strengthen awareness and preventive measures against imported malaria, particularly among Moroccan travelers heading to high-risk countries.
In a circular updating the national guidelines on “chemoprophylaxis against imported malaria,” Tahraoui revealed that Morocco records an average of 550 imported malaria cases annually, primarily involving Moroccan and foreign travelers returning from sub-Saharan Africa.
Although Morocco was certified malaria-free by the World Health Organization in 2010, the country continues to receive hundreds of imported cases each year, the health ministry noted.
The minister said the most affected groups include company workers, truck drivers, and students, who together account for 70% of all recorded cases. Additionally, 90% of the infections involve the Plasmodium falciparum parasite, which is considered the most dangerous strain of malaria.
In response, Tahraoui announced an update to the country’s malaria chemoprophylaxis protocol, now recommending only two medications for prevention: atovaquone-proguanil and doxycycline.
Previously used drugs such as mefloquine and chloroquine are no longer advised, due to increased reports of severe neuropsychiatric side effects linked to mefloquine and rising parasite resistance to chloroquine.
“Malaria remains the world’s most widespread vector-borne parasitic disease, with a heavy concentration in sub-Saharan Africa,” Tihraoui said, noting that the region accounts for over 94% of global cases and fatalities.
The minister stressed that strict adherence to preventive medication and mosquito bite protection is essential for travelers heading to endemic zones. He added that over 90% of global imported malaria cases occur among travelers who failed to follow prevention protocols or did so improperly.
Tahraoui urged medical professionals to proactively guide patients planning to travel to high-risk areas, underlining the importance of timely information and adherence to new medical recommendations.
add your comment
Terms of publication : Not to offend the writer, people, sacred things, or attack religions or the divine self, and refrain from racist incitement and insults.